NS
CLBT icon

NBC Securities’s Cellebrite CLBT Stock Holding History

NBC Securities’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-128
Closed -$2.37K – 2819
2025
Q3 		$2.37K Hold
128
– – ﹤0.01% 2388
2025
Q2 		$2K Hold
128
– – ﹤0.01% 2280
2025
Q1 		$2K Buy
+128
New +$2.69K ﹤0.01% 2011

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

NBC Securities's CLBT Position: Q4 2025 in Review

NBC Securities sold out of Cellebrite (CLBT) in Q4 2025, closing a stake of 128 shares — an estimated $2.37K sold.

NBC Securities first reported a position in CLBT in Q1 2025 and held it in 3 quarters. The position peaked at $2.37K in Q3 2025. 209 funds tracked by Wall St. Rank hold CLBT as of Q4 2025.

  • NBC Securities reported no remaining Cellebrite position as of Q4 2025 after selling out during the quarter.
  • NBC Securities sold 128 Cellebrite shares in Q4 2025, an estimated $2.37K.
  • NBC Securities first reported a position in Cellebrite in Q1 2025 and held it in 3 quarters.
  • NBC Securities's Cellebrite position peaked at $2.37K in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q4 2025.

Based on NBC Securities's 13F filing for Q4 2025, filed 29 Jan 2026.